Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:11 AM
Ignite Modification Date:
2025-12-25 @ 3:11 AM
NCT ID:
NCT00024505
Eligibility Criteria:
Inclusion Criteria:
* Males and females over the age of puberty
* Suspected ARVD based on the presence of major or minor Task Force Criteria
Exclusion Criteria:
* Children younger than 12 years of age
* Internal cardioverter defibrillator (ICD) in place for more than 2 years (for probands)
* Individuals with monomorphic ventricular ectopy of predominantly RBBB morphology
* Individuals with obvious cardiomyopathic abnormalities of structure or function predominantly affecting the left ventricle
* Individuals with other conditions that might be mistaken for right ventricular dysplasia such as congenital heart disease, e.g., atrial septal defect, anomalous drainage of the pulmonary vessels into the right atrium, and Ebstein's malformation
* Individuals unwilling to undergo diagnostic testing at the nearest enrolling center
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
90 Years
Study:
NCT00024505
Study Brief:
Protocol Section:
NCT00024505